MedPath

Comparative study to evaluate the Effectiveness of GanjhuVirTM a herbal antiviral in Cases of Dengue Fever with Thrombocytopenia

Phase 2
Completed
Conditions
Health Condition 1: B338- Other specified viral diseases
Registration Number
CTRI/2019/01/017096
Lead Sponsor
Radhika Ayurveda Research and Development
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Male or Female Subject aged between 18 and 60 years

2.Diagnosis confirmed as DF Grade 1.

3.Platelet count is below 100,000 and above 30,000 per µL

4.ALT/SGPT level less than 165 U/L

5.Subject willingly giving written informed consent

Exclusion Criteria

1.Patient diagnosed with DHF Grade 3 or 4

2.Platelet levels are less than 30,000 per µL

3.Patient is either pregnant or lactating

4.Has received blood products or blood transfusion during the current hospital stay Or during last one month

5.Is the patient diagnosed with ITP, Leukaemia or Hemophilia

6.Serum Creatinine is more than 1.4 mg/dl (if female) or 1.5mg/dl (if male)

7.Patient has participated in another trial within past one month

8.Patient with positive HIV infection

9.The investigator can exclude patient at his/her discretion depending upon the condition of the patient.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in mean platelet countTimepoint: Screening visit, Visit 1 Day1,Visit 2 Day3, Visit 3 Day5
Secondary Outcome Measures
NameTimeMethod
Change in global assessment for overall improvement <br/ ><br>Percentage of participants with adverse events <br/ ><br>Changes in the vitals, Tolerability of study <br/ ><br>drugs, myalgia etc.Timepoint: Screening visit, Visit 1 Day1,Visit 2 Day3, Visit 3 Day5
© Copyright 2025. All Rights Reserved by MedPath